๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Rheumatoid Arthritis (RA)
Clinical trial register · China

Rheumatoid Arthritis (RA) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 11 Wuhan 4 Shanghai 4 Tianjin 1 Yiwu 1
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing11 Wuhan4 Shanghai4 Tianjin1 Yiwu1
All 10 locations
Target enrolment
to

Rheumatoid Arthritis (RA) trials in China

21 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs
NCT07748728Rheumatoid Arthritis (RA)
Hangzhou Highlightll Pharmaceutical Co., Ltd
Phase 2
90
Beijing
2026-08-14
Not yet open
A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis
NCT07684157Rheumatoid Arthritis (RA)
Jacobio Pharmaceuticals Co., Ltd.
Phase 2
32
Beijing
2026-07-29
Recruiting
Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis
NCT07347860Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
12
Wuhan
2026-01-08
Not yet open
Rehabilitation Exercise Intervention for Rheumatoid Arthritis Patients Using Artificial Intelligence-Based Exercise Prescription System
NCT07246811Rheumatoid Arthritis (RA)
Peking University Third Hospital
Not applicable
147
Beijing
2025-11-30
Recruiting
Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis
NCT07721142Rheumatoid Arthritis (RA)
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Phase 4
300
Shanghai
2025-10-15
Recruiting
A Phase 1 Study of ADI-001 in Rheumatoid Arthritis
NCT07100873Rheumatoid Arthritis (RA)
Adicet Therapeutics
Phase 1
25
Shanghai
2025-10-10
Recruiting
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
NCT07301892Rheumatoid Arthritis (RA, Osteoporosis, Osteoarthritis, Interstitial Lung Disease
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Observational
100
Beijing
2025-10-01
Recruiting
Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis
NCT07408024Rheumatoid Arthritis (RA)
Toll Biotech Co. Ltd. (Beijing)
Phase 2
24
Bengbu, Beijing, Puyang, Hohhot, Pingxiang, Linfen
2025-09-10
Recruiting
Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis
NCT07484243Rheumatoid Arthritis (RA), Rheumatoid Arthritis-Associated Interstitial Lung Disease, Difficult-to-Treat Rheumatoid Arthritis
Dongyi He
Observational
10,000
Shanghai
2025-08-22
Recruiting
Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants
NCT07182656Rheumatoid Arthritis (RA)
Yi Fang
Phase 1
70
Beijing
2025-08-18
Not yet open
A Study of Iguratimod in Combination With Tofacitinib in RA Patients
NCT06945666Rheumatoid Arthritis (RA
Jie Chang
Phase 4
200
Yiwu
2025-08-01
Recruiting
An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis
NCT06946199Rheumatoid Arthritis (RA)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
28
Wuhan
2025-06-23
Not yet open
Telitacicept for the Treatment of Refractory RA
NCT07008196Rheumatoid Arthritis (RA)
Chinese SLE Treatment And Research Group
Phase 4
30
Beijing
2025-06-10
Not yet open
Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection
NCT06982547Rheumatoid Arthritis (RA)
DrugUTAA91
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1
24
Wuhan
2025-06
Recruiting
The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection
NCT07001956Rheumatoid Arthritis (RA)
DrugUTAA91
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
24
Wuhan
2025-05-30
Recruiting
Research on the Application of 99mTc-TCR-FAPI SPECT Imaging in Rheumatoid Arthritis
NCT07138729Rheumatoid Arthritis (RA)
Luo Yaping
Not applicable
20
Beijing
2025-05-10
Recruiting
HiSCs in the Treatment of Rheumatoid Arthritis
NCT06947746Rheumatoid Arthritis (RA)
Shanghai Changzheng Hospital
Not applicable
15
Shanghai
2025-05-01
By invitation
Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis
NCT06726096Rheumatoid Arthritis (RA), Anti IL-6R
Beijing VDJBio Co., LTD.
Phase 3
615
Beijing
2025-04-09
Recruiting
A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients
NCT06946641Atopic Dermatitis, Hidradenitis Suppurativa (HS), Rheumatoid Arthritis (RA)
Shanghai Qilu Pharmaceutical Research and Development Center LTD
Phase 1
102
Beijing
2025-03-31
Recruiting
Safety Study of CC312 in Autoimmune Disease Patients
NCT06888960Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathy (IIM), Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA)
DrugCC312
CytoCares Inc
Phase EARLY_PHASE1
18
Tianjin
2024-11-08
Recruiting
A RWS of SC MTX in Chinese RA Patients
NCT07463937Rheumatoid Arthritis (RA)
Peking University People's Hospital
Observational
10,000
Beijing
2024-09-03
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/rheumatoid-arthritis-ra

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies listing the condition Rheumatoid Arthritis (RA).

How many Rheumatoid Arthritis (RA) trials are recruiting in China?

14 of the 21 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 6 have not yet opened recruitment, 0 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Rheumatoid Arthritis (RA)), 21 studies
PhaseStudiesRecruitingShare
Phase 14419%
Phase EARLY_PHASE14319%
Not applicable3214.3%
Observational3314.3%
Phase 23114.3%
Phase 43114.3%
Phase 3104.8%

Most active sponsors

Lead sponsors with the most studies (Rheumatoid Arthritis (RA))
Lead sponsorStudiesRecruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology33
Adicet Therapeutics11
Beijing VDJBio Co., LTD.10
Chinese SLE Treatment And Research Group10
CytoCares Inc11
Dongyi He11
Guang'anmen Hospital of China Academy of Chinese Medical Sciences11
Hangzhou Highlightll Pharmaceutical Co., Ltd10
Jacobio Pharmaceuticals Co., Ltd.10
Jie Chang10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.